AstraZeneca Cambridge
United Kingdom (UK)
1 June 2020 - 31 May 2021
Parent institution: AstraZeneca UK Limited
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for AstraZeneca Cambridge published between 1 June 2020 - 31 May 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 24 | 4.69 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 19 | 3.22 | |
| Chemistry | 5 | 1.61 | |
Top articles by Altmetric score in current window
Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
Nature Immunology
2020-08-03
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
Nature Communications
2021-03-31
Bicyclic β‐sheet mimetics that target the transcriptional coactivator β‑catenin and inhibit Wnt signaling
Angewandte Chemie International Edition
2021-03-29
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects
Nature Immunology
2020-11-23
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
